Clinical trial platform Science 37 latest digital health startup to enter SPAC
Photo by Geber86/Getty Images Science 37, a decentralized clinical trial operating system developer, has shared its going public through a merger with special purpose acquisition company LifeSci Acquisition II Corp. Upon completion of the deal, which is expected to close in the third quarter of 2021, the combined company will operate as Science 37 and will trade on the NASDAQ under the ticker symbol “SNCE.” Science 37 will have an initial enterprise value of approximately $1.05 billion. Th...
David Coman Health Affairs Current Health Lifesci Acquisition Ii Corp Lifesci Acquisition Operating System
Source: mobihealthnews.com